title: Risk factors for ritonavir intolerance and outcome after change to indinavir.
authors.forename: J L
authors.initials: JL
authors.lastname: Casado
authors.forename: M J
authors.initials: MJ
authors.lastname: Perez-Elías
authors.forename: A
authors.initials: A
authors.lastname: Antela
authors.forename: P
authors.initials: P
authors.lastname: Martí-Belda
authors.forename: S
authors.initials: S
authors.lastname: de Lucas
authors.forename: V
authors.initials: V
authors.lastname: Muñoz
authors.forename: A
authors.initials: A
authors.lastname: Guerrero
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004361:Drug Tolerance; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D019469:Indinavir / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D019438:Ritonavir / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D019469:Indinavir; D019438:Ritonavir